AAAAAA
Results:
1-12
|
Results: 12
Authors:
TOLOMEO M
DUSONCHET L
MELI M
GRIMAUDO S
DALESSANDRO N
PAPOFF G
RUBERTI G
RAUSA L
Citation: M. Tolomeo et al., THE CD95 CD95 LIGAND SYSTEM IS NOT THE MAJOR EFFECTOR IN ANTICANCER DRUG-MEDIATED APOPTOSIS/, Cell death and differentiation, 5(9), 1998, pp. 735-742
Authors:
GRIMAUDO S
TOLOMEO M
CHIMIRRI A
ZAPPALA M
GANCITANO RA
DALESSANDRO N
Citation: S. Grimaudo et al., SELECTIVE INDUCTION OF APOPTOSIS IN MULTIDRUG-RESISTANT HL60R CELLS BY THE THIAZOLOBENZOIMIDAZOLE DERIVATIVE DIFLUOROPHENYL)-1H,3H-THIAZOLO[3,4-A]BENZIMIDAZOLE (TBZ), European journal of cancer, 34(11), 1998, pp. 1756-1763
Authors:
MELI M
TOLOMEO M
DALESSANDRO N
GRIMAUDO S
RUBERTI G
PAPOFF G
RAUSA L
DUSONCHET L
Citation: M. Meli et al., RESISTANCE TO GEMCITABINE (OEM) IN A FAS-LIGAND (FASL)-RESISTANT CELL-LINE IS NOT DEPENDENT ON THE FAS FASL (CD95/CD95L) SYSTEM/, Annals of oncology, 9, 1998, pp. 638-638
Authors:
DALESSANDRO N
FLUGY A
TOLOMEO M
DUSONCHET L
Citation: N. Dalessandro et al., THE APOPTOTIC SIGNALING OF TNF-ALPHA IN MULTIDRUG-RESISTANT FRIEND-LEUKEMIA CELLS, Anticancer research, 18(4C), 1998, pp. 3065-3072
Authors:
MUSSO M
PORRETTO F
CRESCIMANNO A
BONDI F
POLIZZI V
SCALONE R
TOLOMEO M
MARIANI G
Citation: M. Musso et al., ONLY ASSOCIATION OF LOW CONCENTRATIONS OF IDARUBICIN PLUS IDARUBICINOL INDUCED APOPTOSIS ON LEUKEMIC-CELLS, Leukemia research, 22(6), 1998, pp. 561-561
Authors:
GRIMAUDO S
TOLOMEO M
GANCITANO RA
DALESSANDRO N
AIELLO E
Citation: S. Grimaudo et al., EFFECTS OF HIGHLY PURIFIED ANTHRAQUINOID COMPOUNDS FROM ALOE-VERA ON SENSITIVE AND MULTIDRUG-RESISTANT LEUKEMIA-CELLS, Oncology Reports, 4(2), 1997, pp. 341-343
Authors:
CARRECA I
CUCCIARRE S
TOLOMEO M
RAUSA L
DIANA G
VECCHIONE A
Citation: I. Carreca et al., CANCER APOPTOSIS - A POSSIBLE NOVEL TOOL TO EVALUATE PROGNOSIS AND EFFECTIVENESS OF THERAPY IN BREAST AND COLON-CANCER, European journal of cancer, 33, 1997, pp. 204-204
Authors:
TOLOMEO M
GANCITANO RA
MUSSO M
PORRETTO F
PERRICONE R
ABBADESSA V
CAJOZZO A
Citation: M. Tolomeo et al., COMPARATIVE ACTIVITY OF IDARUBICIN AND IDARUBICINOL IN COMBINATION WITH CYCLOSPORINE-A IN MULTIDRUG-RESISTANT LEUKEMIA-CELLS, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 157-161
Authors:
TOLOMEO M
GANCITANO RA
MUSSO M
PORRETTO F
VOCASKOVA I
ABBADESSA V
PERRICONE R
CAJOZZO A
Citation: M. Tolomeo et al., EFFECTS OF IDARUBICIN AND IDARUBICINOL IN COMBINATION WITH CYCLOSPORINE-A IN CELLS DISPLAYING THE MULTIDRUG-RESISTANT (MDR) PHENOTYPE, Journal of experimental & clinical cancer research, 14(1), 1995, pp. 134-135
Authors:
TOLOMEO M
GANCITANO RA
MUSSO M
PORRETTO F
VOCASKOVA I
ABBADESSA V
PERRICONE R
CAJOZZO A
Citation: M. Tolomeo et al., ACTIVITY AND PHARMACOKINETICS OF VERAPAMIL, CYCLOSPORINE-A AND R-TELUDIPINE (GR66234A) IN MULTIDRUG-RESISTANT CELLS, Journal of experimental & clinical cancer research, 14(1), 1995, pp. 136-137
Authors:
TOLOMEO M
GANCITANO RA
MUSSO M
PORRETTO F
PERRICONE R
ABBADESSA V
CAJOZZO A
Citation: M. Tolomeo et al., EFFECTS OF R-ENANTIOMER (GR66234A) AND L-ENANTIOMER (GR66235A) OF TELUPIDINE, A NEW DIHYDROPYRIDINE DERIVATIVE, ON CELL-LINES DISPLAYING THE MULTIDRUG-RESISTANT PHENOTYPE, Haematologica, 79(4), 1994, pp. 328-333
Authors:
CROSTA L
CANDILORO V
MELI M
TOLOMEO M
RAUSA L
DUSONCHET L
Citation: L. Crosta et al., LACIDIPINE AND JOSAMYCIN - 2 NEW MULTIDRUG-RESISTANCE MODULATORS, Anticancer research, 14(6B), 1994, pp. 2685-2689
Risultati:
1-12
|